Assenagon Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74,325
| Closed | -$1.63M | – | 1130 |
|
|
2025
Q1 | $1.63M | Buy |
74,325
+44,332
| +148% | +$970K | ﹤0.01% | 786 |
|
|
2024
Q4 | $957K | Sell |
29,993
-2,114,422
| -99% | -$67.5M | ﹤0.01% | 1087 |
|
|
2024
Q3 | $61.8M | Buy |
2,144,415
+1,409,707
| +192% | +$40.7M | 0.11% | 143 |
|
|
2024
Q2 | $28.2M | Sell |
734,708
-1,288,906
| -64% | -$49.4M | 0.06% | 210 |
|
|
2024
Q1 | $119M | Sell |
2,023,614
-121,390
| -6% | -$7.14M | 0.28% | 53 |
|
|
2023
Q4 | $128M | Buy |
2,145,004
+1,121,497
| +110% | +$67.1M | 0.34% | 45 |
|
|
2023
Q3 | $38.9M | Buy |
1,023,507
+524,797
| +105% | +$20M | 0.12% | 140 |
|
|
2023
Q2 | $45.4M | Sell |
498,710
-244,536
| -33% | -$22.3M | 0.16% | 101 |
|
|
2023
Q1 | $49M | Buy |
743,246
+15,517
| +2% | +$1.02M | 0.17% | 98 |
|
|
2022
Q4 | $37.6M | Sell |
727,729
-497,607
| -41% | -$25.7M | 0.14% | 133 |
|
|
2022
Q3 | $83.7M | Buy |
1,225,336
+341,898
| +39% | +$23.4M | 0.32% | 58 |
|
|
2022
Q2 | $39.9M | Buy |
883,438
+370,411
| +72% | +$16.7M | 0.15% | 118 |
|
|
2022
Q1 | $26.1M | Buy |
513,027
+445,745
| +663% | +$22.6M | 0.07% | 190 |
|
|
2021
Q4 | $3.18M | Buy |
+67,282
| New | +$3.18M | 0.01% | 628 |
|
|
2021
Q3 | – | Sell |
-235,775
| Closed | -$14.9M | – | 1237 |
|
|
2021
Q2 | $14.9M | Buy |
+235,775
| New | +$14.9M | 0.05% | 241 |
|
|
2020
Q4 | – | Sell |
-16,433
| Closed | -$496K | – | 959 |
|
|
2020
Q3 | $496K | Buy |
+16,433
| New | +$496K | ﹤0.01% | 926 |
|
|
2019
Q4 | – | Sell |
-24,312
| Closed | -$586K | – | 716 |
|
|
2019
Q3 | $586K | Buy |
+24,312
| New | +$586K | ﹤0.01% | 633 |
|
|
2019
Q2 | – | Sell |
-308,992
| Closed | -$6.03M | – | 959 |
|
|
2019
Q1 | $6.03M | Buy |
+308,992
| New | +$6.03M | 0.06% | 236 |
|